Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.

Common decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal ...

Once the nasal spray is absorbed through the membranes in the nose, it enters the bloodstream and works to stimulate melanin ...

ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.

Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to expand ...

Nasal sprays, especially decongestant nasal sprays (DNSs), offer quick relief by shrinking swollen blood vessels in the nasal ...

Vaccines delivered through a spray into the nose could offer better protection and fewer side effects than traditional vaccine shots in the arm.

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

TurboFil's fully automated UDS Vial Filling & Assembly System produces up to 100 unidose nasal spray devices per minute and ...

Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...